Scandinavian ChemoTech strengthens finances by raising a loan of 2.5 MSEK from board and CEO
16 augusti, 2022
16 augusti, 2022
The agreement signed today strengthens the Company's finances to ensure its ongoing operations.
The loan is taken out at an interest rate of 4% per quarter on the granted loan. The lenders will be given the opportunity to use all or part of the disbursed loan, including accrued and unpaid interest, as an offset in the event of a new issue.
“I appreciate the support from the board to extend our operations into 2023 which gives us enough time to raise long-term capital as well as continue our revenue-focused strategy."-says Mohan Frick, CEO of Scandinavian ChemoTech
"We are in a very exciting period in the company's life with plenty of milestones met and we look forward tocontinue our commercialisation process." - says Lars Hedbys, Chairman of the Board of Scandinavian ChemoTech
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-08-2022 08:15 CET.
16 augusti, 2022
The agreement signed today strengthens the Company's finances to ensure its ongoing operations.
The loan is taken out at an interest rate of 4% per quarter on the granted loan. The lenders will be given the opportunity to use all or part of the disbursed loan, including accrued and unpaid interest, as an offset in the event of a new issue.
“I appreciate the support from the board to extend our operations into 2023 which gives us enough time to raise long-term capital as well as continue our revenue-focused strategy."-says Mohan Frick, CEO of Scandinavian ChemoTech
"We are in a very exciting period in the company's life with plenty of milestones met and we look forward tocontinue our commercialisation process." - says Lars Hedbys, Chairman of the Board of Scandinavian ChemoTech
This disclosure contains information that ChemoTech is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 16-08-2022 08:15 CET.


Aktieanalys
Aktieråd
Nvidia-krisen

Anthropics IPO


Aktieanalys
Aktieråd
Nvidia-krisen

Anthropics IPO
1 DAG %
Senast

OMX Stockholm 30
−0,07%
(vid stängning)
NYAB
Igår, 07:00
NYAB: Bygger för nästa lyft
Alfa Laval
14 november, 07:00
Torsten Jansson om börsklippet: ”Jag hade rätt”
Stockholmsbörsen
13 november, 17:42
Hemnet föll tvåsiffrigt – börsen kring nollan
Anthropic
13 november, 17:09
Anthropics IPO stoppar investerare från Kina och Hongkong
Federal Reserve
13 november, 17:06
Feds Boston-chef öppnar för högre räntor
OMX Stockholm 30
1 DAG %
Senast
3 356,87